The patent allowance reduces technology risk and could attract partnership or acquisition interest; monitor for follow-on IP developments or commercial updates. Given VTAK's small market cap ($3M), even modest strategic progress could have outsized stock impact.
Price Chart
Executive Summary
Catheter Precision, Inc. (VTAK) announced a Notice of Allowance from the USPTO for key patents covering its surgical vessel closing pressure device, strengthening its intellectual property position and competitive moat in the medical device space.
Key Facts
- USPTO issued a Notice of Allowance for key claims covering VTAK's proprietary vessel closing pressure device.
- Patent protection covers both core device architecture and method of use, enhancing IP defensibility.
- Technology enables precise control of suture tension and pressure application post-vascular procedures.
- LockeT, a related Class 1 device, is FDA-registered and has CE Mark approval.
- Management emphasizes long-term value creation and strategic opportunities from IP expansion.
Financial Impact
Non-dilutive value enhancement through strengthened IP; no immediate revenue impact but improves commercialization and licensing potential.
Risk Factors
- Forward-looking statements are subject to risks and uncertainties.
- No assurance that patent allowance will lead to commercial success or revenue generation.
- Company remains early-stage with unproven market adoption.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3277839 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 25d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 25d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 29d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 11w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 12w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers